Skip to main content
Christopher Clark, MD, Physical Medicine/Rehab, Hagerstown, MD

Christopher David Clark MD

Pain Medicine, Sports Medicine (Non-Surgical)


Pain Management, Sports Medicine. Premier Spine and Sports Medicine

Join to View Full Profile
  • 13114 Pennsylvania AveHagerstown, MD 21742

  • Phone+1 301-800-7770

  • Fax+1 301-800-7891

Dr. Clark is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Performance Spine & Sports Medicine
    Performance Spine & Sports MedicineFellowship, Pain Medicine, 2014 - 2015
  • Sinai Hospital of Baltimore
    Sinai Hospital of BaltimoreResidency, Physical Medicine and Rehabilitation, 2011 - 2014
  • ECU Health Medical Center/East Carolina University
    ECU Health Medical Center/East Carolina UniversityInternship, Internal Medicine, 2010 - 2011
  • Brody School of Medicine at East Carolina University
    Brody School of Medicine at East Carolina UniversityClass of 2010

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2016 - 2026
  • PA State Medical License
    PA State Medical License 2014 - 2026
  • NJ State Medical License
    NJ State Medical License 2014 - 2019
  • NC State Medical License
    NC State Medical License 2010 - 2011
  • Physical Medicine & Rehabilitation
    American Board of Physical Medicine and Rehabilitation Physical Medicine & Rehabilitation

Press Mentions

  • Idorsia Pharmaceuticals Announces Support for a Clinical Trial Being Conducted by the U.S. Department of Defense Evaluating QUVIVIQ (Daridorexant) as Potential Therapy for Treatment of Posttraumatic Stress Disorder (PTSD)
    Idorsia Pharmaceuticals Announces Support for a Clinical Trial Being Conducted by the U.S. Department of Defense Evaluating QUVIVIQ (Daridorexant) as Potential Therapy for Treatment of Posttraumatic Stress Disorder (PTSD)May 10th, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: